Tenascin C in Lung Diseases
Biology · 28.01.2023 · 12 (2) · 199
DOI: 10.3390/biology12020199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology, online erschienen am 28.01.2023. Verfasst von Chantal Donovan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Research Grant Council of The Hong Kong Special Administrative Region China, RGC of the Hong Kong Special Administrative Region.
Abstract (Originalsprache)
Tenascin C (TNC) is a multifunctional large extracellular matrix protein involved in numerous cellular processes in embryonic development and can be increased in disease, or under conditions of trauma or cell stress in adults. However, the role of TNC in lung diseases remains unclear. In this study, we investigated the expression of TNC during development, in offspring following maternal particulate matter (PM) exposure, asthma, chronic obstructive pulmonary disease (COPD) and lung cancer. TNC expression is increased during lung development in biopsy cells, endothelial cells, mesenchymal cells, and epithelial cells. Maternal PM exposure increased TNC and collagen deposition, which was not affected by the removal of PM exposure after pregnancy. TNC expression was also increased in basal epithelial cells and fibroblasts in patients with asthma and AT2 and endothelial cells in patients with COPD. Furthermore, there was an increase in the expression of TNC in stage II compared to stage IA lung cancer; however, overall survival analysis showed no correlation between levels of TNC and survival. In conclusion, TNC is increased during lung development, in offspring following maternal PM exposure, and in asthma, COPD, and lung cancer tissues. Therefore, targeting TNC may provide a novel therapeutic target for lung diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.
- Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW 2050, Australia.
- Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia.
- Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.
- Air Quality Studies, Department of Civil and Environmental Engineering, Hong Kong Polytechnic University, Hong Kong SAR 999077, China.
ORCID-Profile: Kin-Fai Ho, Hui Chen, Brian G Oliver
Förderung
- National Health and Medical Research Council
- Research Grant Council of The Hong Kong Special Administrative Region China
- RGC of the Hong Kong Special Administrative Region
- the Strategic Focus Area scheme of The Research Institute for Sustainable Urban Development at The Hong Kong Polytechnic University
- National Health & Medical Research Council (NHMRC) Australia
- Peter Doherty Fellowship by NHMRC Australia
- Council of The Hong Kong Special Administrative Region China
Zitieren
APA
Donovan, C., Bai, X., Chan, Y. L., Feng, M., Ho, K. F., Guo, H., Chen, H., & Oliver, B. G. (2023). Tenascin C in Lung Diseases. Biology, 12(2), 199. https://doi.org/10.3390/biology12020199
Vancouver
Donovan C, Bai X, Chan YL, Feng M, Ho KF, Guo H, et al. Tenascin C in Lung Diseases. Biology. 2023;12(2):199. doi:10.3390/biology12020199
BibTeX
@article{Donovan2023,
author = {Donovan, Chantal and Bai, Xu and Chan, Yik Lung and Feng, Min and Ho, Kin-Fai and Guo, Hai and Chen, Hui and Oliver, Brian G},
title = {Tenascin C in Lung Diseases},
journal = {Biology},
year = {2023},
volume = {12},
number = {2},
pages = {199},
doi = {10.3390/biology12020199}
}
EUVIMED